Sebastian T. Balbach
banner
balbachlab.bsky.social
Sebastian T. Balbach
@balbachlab.bsky.social
Physician scientist, Pediatric leukemia and sarcoma, Epigenetics and Cancer stem cells, University Hospital Münster, Germany
Reposted by Sebastian T. Balbach
An international team led by Dr Thilo von Groote and Prof Alexander Zarbock shows that a targeted preventive strategy after major surgery significantly reduces the risk of severe acute #kidney injury, published in @thelancet.com
Prevention reduces the incidence of severe acute kidney injury after major surgery
In an article published in the journal The Lancet, an international research team led by Dr Thilo von Groote and Prof Alexander Zarbock from the University of Münster has demonstrated that a targeted ...
www.uni-muenster.de
December 10, 2025 at 1:14 PM
Reposted by Sebastian T. Balbach
Join us for our annual christmas lecture on December 16th at 5 pm in the lecture hall C1. This year, Uwe Karst and Michael Holtkamp explore the fascination of light under the topic "Let there be light!". How do we perceive it? How can we make colorful light? And how does chemistry come into play?
November 18, 2025 at 9:47 AM
Reposted by Sebastian T. Balbach
A big advance, folks, for off-the-shelf, universal, engineered (base-edited) T cells achieving complete response vs incurable leukemia in several patients
www.nejm.org/doi/full/10....
December 8, 2025 at 10:10 PM
Reposted by Sebastian T. Balbach
In relapsed or refractory T-cell acute lymphoblastic leukemia, off-the-shelf allogeneic base-edited CAR7 T cells mediated responses in 11 patients, enabling stem-cell transplantation in 9 patients in deep remission. Full study results: nej.md/48wiyQL

#ASH25 | @ash.hematology.org
December 8, 2025 at 9:35 PM
Reposted by Sebastian T. Balbach
Every single person working today in every branch of cell and gene therapy - viral, nonviral, editing, transgenesis - owes a deep debt of gratitude to Dr. High.
“I had hemophilia for nearly five decades. I went to Philadelphia and had a 45-minute infusion, and my hemophilia was gone.”
Genes-> Medicine

nature.com/articles/s41...
November 21, 2025 at 10:23 PM
Reposted by Sebastian T. Balbach
“I had hemophilia for nearly five decades. I went to Philadelphia and had a 45-minute infusion, and my hemophilia was gone.”
Genes-> Medicine

nature.com/articles/s41...
November 21, 2025 at 9:45 PM
Reposted by Sebastian T. Balbach
Why is immune escape such a problem with SARS-CoV-2?
Analysis of >1,000 antibodies to the spike protein to help design a workaround plan
www.cell.com/cell-systems...
One thousand SARS-CoV-2 antibody structures reveal convergent binding and near-universal immune escape
Feng et al. analyze over 1,100 SARS-CoV-2 antibody structures, including all 13 clinical monoclonals, mapping 99% of the receptor-binding domain surface. Their study reveals convergent paratope archit...
www.cell.com
November 21, 2025 at 4:46 PM
Reposted by Sebastian T. Balbach
Holy mother of my personal lord Gregor Mendel.
We now have WHAT?!?
November 21, 2025 at 4:54 PM
Reposted by Sebastian T. Balbach
Take a 13 min break for an interesting discussion on the potential impact of COVID mRNA vaccines on cancer treatments & cancer patients.

Ira talks with Adam Grippin (@mdanderson.bsky.social) and @erictopol.bsky.social (The Scripps Research Inst.).

www.sciencefriday.com/segments/cov...
Study Finds COVID mRNA Vaccines Boost Cancer Treatment
New research found that mRNA vaccines for COVID-19 could enhance cancer treatments and help patients live longer.
www.sciencefriday.com
November 10, 2025 at 7:12 PM
Reposted by Sebastian T. Balbach
Announcing our new preprint! We built SPICE, a framework that combines large-scale experiments and generative AI to design RNA sequences that control cell type-specific gene expression using alternative splicing – a powerful, underexplored modality.

Preprint: www.biorxiv.org/content/10.1...
(1/10)
Generative Design of Cell Type-Specific RNA Splicing Elements for Programmable Gene Regulation
Programmable control of gene expression in specific cell types is essential for both basic discovery and therapeutic intervention, yet current strategies lack scalability across diverse cellular conte...
www.biorxiv.org
November 6, 2025 at 6:59 PM
Reposted by Sebastian T. Balbach
And the Abstract
November 5, 2025 at 1:08 AM
Reposted by Sebastian T. Balbach
Here's the graph
November 5, 2025 at 1:08 AM
Reposted by Sebastian T. Balbach
For children and teens, heart and blood vessel complications of Covid overshadow the very rare and short-term risk of vaccinations, a new report from nearly 14 million kids
www.thelancet.com/journals/lan...
November 5, 2025 at 12:48 AM
Reposted by Sebastian T. Balbach
“Ah, it's your first gastroenteritis. It gets easier.”

The latest video in our partnership with @glaucomflecken.bsky.social summarizes recent research on the effects of ondansetron after emergency visits in children with gastroenteritis-associated vomiting. 👉 nej.md/DrG29
November 4, 2025 at 8:03 PM
Reposted by Sebastian T. Balbach
Myelin damage in multiple sclerosis can be detected up to seven years before symptoms, with early immune pathway activation and a 21-protein panel showing promise for presymptomatic diagnosis, according to a paper in Nature Medicine. go.nature.com/4qqq47L #medsky 🧪
November 1, 2025 at 1:50 AM
Reposted by Sebastian T. Balbach
How do you change a cold, immune evasive tumor into a hot one?
erictopol.substack.com/p/how-mrna-v...
October 28, 2025 at 10:40 AM
Reposted by Sebastian T. Balbach
Nature research paper: SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade

go.nature.com/477I3sj
SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade - Nature
mRNA vaccines targeting SARS-CoV-2 also sensitize tumours to immune checkpoint inhibitors.
go.nature.com
October 28, 2025 at 11:53 AM
Reposted by Sebastian T. Balbach
Neat trick if you polycolonal ab's suck. Incubate them with fixed cells with a KO of your protein of interest, then spin. Protocol here: www.med.upenn.edu/markslab/ass...
I was amazed how well it worked on first try (I'm sure that I can completely eliminate unspecific bands)
#WesternBlot #cellsky
October 2, 2025 at 5:11 PM
Reposted by Sebastian T. Balbach
In a double-blind, randomized, placebo-controlled trial conducted in Uganda, the use of permethrin-treated baby wraps significantly reduced the incidence of clinical malaria among young children. Full trial results and Research Summary: nej.md/4msFwwX

#MedSky #PedSky #IDSky
October 15, 2025 at 1:17 PM
Reposted by Sebastian T. Balbach
A new world record for ultra rapid whole genome sequencing and interpretation for critically ill individuals less than 4hrs! www.nejm.org/doi/full/10....
Toward Same-Day Genome Sequencing in the Critical Care Setting | NEJM
Decisions about critical care are almost always made without access to genetic information. The authors report the application of a new method of DNA sequencing in infants in a neonatal intensive c...
www.nejm.org
October 15, 2025 at 3:29 PM
Reposted by Sebastian T. Balbach
A study in npj Antimicrobials and Resistance shows that ibuprofen and acetaminophen, two commonly consumed pain relief medications, can significantly enhance antibiotic resistance via mutation at gut-relevant concentrations in Escherichia coli. go.nature.com/45Td553 #medsky 🧪
August 29, 2025 at 4:22 PM
Reposted by Sebastian T. Balbach
Excited to see this published with additional data following our preprint a while back. Cool combination (in our biased view) of controlled TF expression and machine learning to decode chromatin sensitivity. www.sciencedirect.com/science/arti....
August 7, 2025 at 4:20 PM
Reposted by Sebastian T. Balbach
Every so often, a paper lands at exactly the right moment. This one’s a gem. Can’t wait to try out this new strategy for delivering CRISPRoff chromatin-editing tools into our favorite cellular model system. Congrats to James K Nuñez and his team: www.nature.com/articles/s41...
Programmable epigenome editing by transient delivery of CRISPR epigenome editor ribonucleoproteins - Nature Communications
Epigenome editing programs gene silencing without inducing DNA breaks but challenges in delivery into human cells limit its broader use. Here, the authors present the RENDER platform, which uses virus...
www.nature.com
August 29, 2025 at 7:27 PM